InspireMD, Inc.
Here’s whether InspireMD, Inc. (NSPR) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-6.05% over 10 days); RSI 14 — oversold; weak 1-year return of -55.8%; 3-month momentum negative (-29.4%); rising volume on a downtrend (distribution, 2.72x avg). Currently 60.8% off its 52-week high. Score: -7/7.
NSPR is trading below its 200-day MA ($1.98) — a key warning sign the longer-term trend is under pressure. An RSI of 14.3 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -55.8% compares to +27.9% for SPY (trailed the market by 83.7%). The current 60.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.